Aspects to be considered by the Heart Team for the decision between TAVR and SAVR in patients at increased surgical risk. Aspects to be considered by the.

Slides:



Advertisements
Similar presentations
Secondary Prevention Following Coronary Artery Bypass Grafting: are we Compliant with the Guidelines? V. Joshi, B. Bridgewater University Hospital of South.
Advertisements

PARTNER Objective To compare surgical aortic valve replacement (AVR) with transcatheter aortic valve replacement (TAVR) in high-risk patients with severe.
© 2012 EuroIntervention. All rights reserved. EuroIntervention 2009;5: A comparison of patient characteristics and 30-day mortality outcomes after.
Figure 1 Causes of bioprosthetic valve dysfunction.
Anita W. Asgar MD, FRCPC, FACC Montreal Heart Institute
Relation of aortic regurgitation to all-cause mortality in the transcatheter aortic valve replacement (TAVR) as-treated population of the Placement of.
The Aortic Valve Patient Learning Objectives
Are we ready for expanding TAVI indications to moderate and low risk
From: Functional Status and Quality of Life After Transcatheter Aortic Valve ReplacementA Systematic Review Ann Intern Med. 2014;160(4): doi: /M
Transcatheter aortic valve replacement in patients with severe aortic stenosis who are at high risk for surgical complications: Summary assessment of.
Nat. Rev. Cardiol. doi: /nrcardio
Transcatheter and Surgical Aortic Valve Replacement in Dialysis Patients: A Propensity- Matched Comparison  Dale M. Kobrin, BA, Fenton H. McCarthy, MD,
Comparison between Kaplan-Meier survival estimates of Bristol aortic valve surgery patients and the Monte Carlo-based generated Kaplan-Meier curve using.
Comparison between Kaplan-Meier survival estimates of Bristol aortic valve surgery patients and the Monte Carlo-based generated Kaplan-Meier curve using.
An example adjunctive CT imaging in the management of aortic valve replacement dysfunction. An example adjunctive CT imaging in the management of aortic.
Kaplan-Meier survival curves comparing survival between both time periods according to management strategy. Survival in patients with infective endocarditis.
Update in Cardiac and Thoracic Surgery
Ao, aorta; AR, aortic regurgitation; CFD, color-flow Doppler; LV, left ventricle; LV EDP, left ventricular end-diastolic pressure; PW, pulse-wave; SBP,
Management of Patients With Aortic Valve Stenosis
Transcatheter or Surgical Aortic Valve Replacement in Patients With Prior Coronary Artery Bypass Grafting  John V. Conte, MD, Thomas G. Gleason, MD, Jon.
Nat. Rev. Cardiol. doi: /nrcardio
Johannes Steiner et al. JACC 2017;70:
Johannes Steiner et al. JACC 2017;70:
The Mitral Valve Patient Learning Objectives
Ruben L. J. Osnabrugge, MSc, Stuart J. Head, MSc, Tessa S. S
Date of download: 2/22/2017 © The European Society of Cardiology All rights reserved. For permissions please
Nat. Rev. Cardiol. doi: /nrcardio
Change in symptoms in operated and unoperated patients 1 year following evaluation of surgical AVR. Pie charts display change from baseline to follow-up.
Gorav Ailawadi, MD, Damien J. LaPar, MD, MS, Alan M. Speir, MD, Ravi K
Suggested pathway for assessment of aortic valve replacement dysfunction. Suggested pathway for assessment of aortic valve replacement dysfunction. Transthoracic.
Ao, aorta; CEOA, corrected effective orifice area; CFD, color-flow Doppler; CW, continuous-wave; DBP, diastolic blood pressure; LV EDP, left ventricular.
Cost-effectiveness of the Edwards SAPIEN transcatheter heart valve compared with standard management and surgical aortic valve replacement in patients.
Miralem Pasic et al. JCIN 2015;8:1-9
The risk and extent of neurologic events are equivalent for high-risk patients treated with transcatheter or surgical aortic valve replacement  Thomas.
Nicolaj C. Hansson et al. JACC 2016;68:
Transcatheter aortic valve replacement in intermediate-risk patients
Michele Gallo, MD, Gino Gerosa, MD 
Transcatheter aortic valve replacement and surgical aortic valve replacement: Both excellent therapies  J. James Edelman, MBBS(Hons), PhD, Vinod H. Thourani,
Takashi Murashita, MD, Kevin L. Greason, MD, Rakesh M
Figure 1 Selection algorithm of patients being included in the German Aortic Valve Registry in 2014 and Figure 1 Selection algorithm of patients.
Delirium after surgical and transcatheter aortic valve replacement is associated with increased mortality  Hersh S. Maniar, MD, Brian R. Lindman, MD,
Comparison of CMR and echocardiography in aortic regurgitation.
Long-term results estimates for patients with anomalous origin of coronary artery from the pulmonary artery, showing survival, freedom from coronary and.
Flow chart of the 1683 study members at age 60–64 years by hypertension (HT) status. Flow chart of the 1683 study members at age 60–64 years by hypertension.
Distribution of relative percentage change ((post-AVR−pre-AVR)/pre-AVR) in the patients’ absolute pVO2 values between pre-AVR and post-AVR after 9 months.
Multimodality imaging of aortic stenosis.
UK trends in selected aspects of paediatric cardiac surgery case mix between 2000 and 2009/2010. UK trends in selected aspects of paediatric cardiac surgery.
Cost of healthcare and sick leave before and after heart valve surgery (€). Cost of healthcare and sick leave before and after heart valve surgery (€).
Box plot of hospital length of stay (in days) for the STD and TAVI groups before (blue) and after (green) the TAVI/turn-down date. Box plot of hospital.
Potential effect of guidelines on ASCVD prevention in the CGPS*
Transcatheter aortic valve replacement for prime time unrestricted distribution? Not so fast, my friend  G. Michael Deeb, MD, John Carroll, MD  The Journal.
N-terminal pro-B-type natriuretic peptide (NT-proBNP) levels for patients undergoing surgical aortic valve replacement (SAVR) (A), patients undergoing.
Rick A. Nishimura et al. JACC 2019;73:
Rick A. Nishimura et al. JACC 2014;63:e57-e185
Amir A. Mahabadi et al. JIMG 2017;10:
Matias B. Yudi et al. JACC 2018;71:
Commentary: When a choice is not an echo
Summary of STICH trial patients included in the analysis of 6 min walk distance. Reasons for non-inclusion at each follow-up time are given. CABG, coronary.
Percentage distribution of ESC HF subtypes and no cardiac dysfunction (no dysf, n=38) among all 370 included patients, where HFvhd is HF due to valvular.
Deterministic univariate sensitivity analyses (BAV, balloon aortic valvuloplasty; ICU, intensive care unit; MM, medical management; QALY, quality-adjusted.
Racing to the Rubicon  Michael J. Reardon, MD, Vinod H. Thourani, MD 
Risk for cardiovascular disease and all-cause death according to RHR: (A) as categorical variable (HR≥75 bpm vs HR
Trend of complications for patients undergoing bioprosthetic mitral valve replacement (MVR) for mitral regurgitation between 2003 and Trend of complications.
Patient selection process in the present study.
Stefan Toggweiler et al. JCIN 2016;9:
Distribution of patient baseline characteristics among included studies. Distribution of patient baseline characteristics among included studies. Each.
NYHA before and after at least 30–60 days after TAVI
Kaplan-Meier curves showing the probability of symptom-free survival according to the rate of heart rate rise during exercise testing in (A) for the whole.
Proposed future revascularisation strategy in patients with ESRD based on our current results and previous guideline recommendations. Proposed future revascularisation.
Summary of the aortic valve procedures performed in the initial BAV group (A) and the initial SAV group (B), by order of reinterventions (first on the.
Presentation transcript:

Aspects to be considered by the Heart Team for the decision between TAVR and SAVR in patients at increased surgical risk. Aspects to be considered by the Heart Team for the decision between TAVR and SAVR in patients at increased surgical risk. (+) favours TAVR; (–) favours SAVR. Based on the recommendations formulated in the 2017 ESC/EACTS guidelines on the management of valvular heart disease. EACTS, European Association of CardioThoracic Surgery; ESC, European Society of Cardiology, SAVR, surgical aortic valve replacement; TAVR, transcatheter aortic valve replacement. Tasalak Thonghong et al. Open Heart 2018;5:e000753 ©2018 by British Cardiovascular Society